- Market Capitalization, $K 44,984
- Shares Outstanding, K 10,119
- Annual Sales, $ 0 K
- Annual Income, $ -2,500 K
- 60-Month Beta N/A
- Price/Sales N/A
- Price/Cash Flow N/A
- Price/Book 10.57
|Period||Period Low||Period High||Performance|
| || |
+0.10 (+2.33%)since 11/06/19
| || |
-0.63 (-12.52%)since 09/06/19
NEW YORK, NY / ACCESSWIRE / December 2, 2019 / Hoth Therapeutics, Inc. (NASDAQ:HOTH) ("HOTH" or the "Company"), a biopharmaceutical company focused on developing new generation therapies for dermatological...
Atopic dermatitis is a widespread chronic inflammatory skin condition that can affect patients of all ages and is the result of a complex interplay of environmental, immunological, genetic, and pharmacologic...
Wall Street Reporter, the trusted name in financial news since 1843, has recently published published CEO Interviews, and conference presentation videos from some of the most talked about stocks today....
Wall Street Reporter will be hosting the "NEXT SUPER STOCK - Live!" livestream online-only investor conference on Thursday September 26, 2019 from 12:00PM-1:00PM EST. Registration is free. Click here to...
CEO Interviews with: HEXO, HOTH, MDCL, NEXCF
Wall Street Reporter, the trusted name in financial news since 1843, has recently published published CEO Interviews, video presentations, and news updates from the company's presenting at last month's...
According to a report from Grand View Research, the global diabetic foot ulcer treatment market size is expected to reach a value of USD 6.82 billion by 2025, according to a new report by Grand View Research,...